4-methylcatechol has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriambeloson, E; Callizot, N; Cirillo, R; Dreano, M; Ferro, P; Glass, J; Revel, M; Vitte, PA | 1 |
| Furihata, C; Matsushima, T; Oguchi, S | 1 |
2 other study(ies) available for 4-methylcatechol and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Ataxia; Catechols; Cisplatin; Colonic Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neural Conduction; Neuroprotective Agents; Paclitaxel; Pain Threshold; Peripheral Nervous System Diseases; Postural Balance; Rats; Rats, Inbred Strains; Transplantation, Heterologous; Vincristine | 2008 |
Possible tumor-initiating and -promoting activity of p-methylcatechol and methylhydroquinone in the pyloric mucosa of rat stomach.
Topics: Adenocarcinoma; Animals; Carcinogens; Catechols; DNA Damage; DNA Replication; DNA, Single-Stranded; Dose-Response Relationship, Drug; Gastric Mucosa; Hydroquinones; Male; Ornithine Decarboxylase; Pylorus; Rats; Rats, Inbred F344; Stomach Neoplasms; Time Factors | 1993 |